BP000123-C082: Recombinant Rabbit Tumor Necrosis Factor alpha (TNFα) Protein
Source: E. coli-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000124-C181: Recombinant Human Tumor Necrosis Factor β (TNFβ) Protein
Source: E. coli-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP000129-C022: Recombinant Human Tumor Necrosis Factor Ligand Superfamily Member 10 (TNFSF10) Protein
Source: E. coli-derived.
The ED50 as determined by the cytolysis of murine L929 cells in the presence of Actinomycin D is less than 2 ug/ml, corresponding to a Specific Activity of 5.0 x 106 IU/mg.
Purity: > 95% by RP-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000126-C181: Recombinant Human Tumor Necrosis Factor beta (TNF-β) Protein
Source: E. coli-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000129-C326: Recombinant Human Tumor Necrosis Factor Ligand Superfamily Member 10 (TNFSF10) Protein
Source: HEK 293-derived.
Purity: > 95% by reducing SDS-PAGE and SEC-HPLC.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000131-C041: Recombinant Mouse Interleukin-1 alpha (IL-1α) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of mouse D10S cells was found to be less than 0.01 ug/ml, corresponding to a Specific Activity of 1.0 x 108 IU/mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000136-C088: Recombinant Mouse IL-13
Source: E. coli-derived.
The ED50 of rmIL13 as determined by dose-dependent stimulation of proliferation of TF-1 human erythroleukemic cells was < 2 ug/ml, corresponding to a Specific Activity of 5.0 x 105 IU/mg.
Purity > 95%, by reducing SDS-PAGE and SEC-HPLC.
Endotoxin: Less than 0.1 ng/ug (1 EU/ug).BP000131-C070: Recombinant Human Interleukin-1 alpha (IL-1α) Protein
Source: E. coli-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000140-C021: Recombinant Human Interleukin-17A (IL-17A) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependent induction of IL-6 in primary human foreskin fibroblasts was found to be approximately 2 ug/ml, corresponding to a Specific Activity of 5 x 105 IU/mg.
Purity: > 95% by RP-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000134-C006: Recombinant Human Interleukin-11 (IL-11) Protein
Source: P. Pichia-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of murine 7TD1 was found to be less then 0.2 ug/ml, corresponding to a Specific Activity of 8.0 x 106 IU/ mg.
Purity: > 95% by RP-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).